MYCOPHENOLATE MOFETIL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mycophenolate mofetil hydrochloride and what is the scope of patent protection?
Mycophenolate mofetil hydrochloride
is the generic ingredient in two branded drugs marketed by Roche Palo, Amneal, Bpi Labs, Endo Operations, Meitheal, Mylan Labs Ltd, Rising, Steriscience Speclts, and Zydus Pharms, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for mycophenolate mofetil hydrochloride. Eleven suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 9 |
NDAs: | 9 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Clinical Trials: | 954 |
Patent Applications: | 229 |
What excipients (inactive ingredients) are in MYCOPHENOLATE MOFETIL HYDROCHLORIDE? | MYCOPHENOLATE MOFETIL HYDROCHLORIDE excipients list |
DailyMed Link: | MYCOPHENOLATE MOFETIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fred Hutchinson Cancer Center | Phase 2 |
National Cord Blood Network | Phase 2 |
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China | Phase 1 |
Generic filers with tentative approvals for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 500MG | INJECTABLE; INJECTION |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Drug Class | Antimetabolite Immunosuppressant |
US Patents and Regulatory Information for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Expired US Patents for MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.